The Effect of Varying Oral Dosages of Banthine, Probanthine and Prantal on the Galvanic Skin Response1  by Perry, Daniel J. et al.
THE EFFECT OF VARYING ORAL DOSAGES OF BANTHINE, PRO-
BANTHINE AND PRANTAL ON THE GALVANIC SKIN RESPONSE*
DANIEL J. PERRY, M.D.,t GEORGE E. MOUNT, Pu.D.t AND BOYD W.
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Recent experiments have demonstrated the effects on the Galvanic Skin
Resistance (GSR) of certain drugs which either stimulate or suppress sweat gland
activity (1, 2). In a study of sympathectomized subjects, evidence has been pre-
sented which substantiates the theory that the GSR phenomenon is related to
sweat gland activity (3). Significant differences between placebo, atropine and
pilocarpine have also been found regardless of the order of administration (4).
In addition, repeated placebo injections have indicated that no significant adapta-
tion occurred (4).
The results of the above investigations have suggested the possibility of using
the GSR to compare the dose-response effects of certain drugs. Therefore, the
present study was initiated to evaluate varying oral dosages of Banthine (methan-
theline bromide), Pro-B anthine (propantheline bromide), Prantal (diphemanil
methylsulfate) and placebo.
MATERIALS AND METHODS
The subjects for the present experiments were ten normal white males ranging
in age from 19 to 33 years. Each individual was tested separately to 50 and 100
mgm. of Banthiiie, 15 and 30 mgm. of Pro-Banthine, 100 and 200 mgm. of Pran-
tal and a placebo. The order of drug administration was varied in each subject to
obtain an approximate representation of the total iiumber of possible orders. All
tests were made in the morning after breakfast and completed before lunch.
Following the oral administration of the test drug, the GSR was recorded for 90
minutes on a Esterline Angus milliameter using a previously reported technic
(1, 2). The chart record for each test consisted of 24 periods of 3 minutes.
Instrument calibrations were made preceding, at the middle and at the end of
each experiment.
RESULTS
The high and low resistance levels for each 3 3, minute period were determined
by linear interpolation between the calibrations for each record. These values
were then converted intoV'micromhos using the formula (1/R.106)t. The data
for all subjects were averaged separately for each of the seven experimental
conditions and preliminary curves plotted as shown in Figure 1. These results
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FIG. 1. Effect of drugs on GSR level (uncorrected curves)
TABLE 1
Regression coefficients on initial levels
Drug
Time Period
3 12 24
Placebo
Pro-Banthine, 15 mgm
Pro-Banthine,3omgm
Banthine, 50 mgm
Banthine, 100 mgm
Prantal, 100 mgm
Prantal, 200 mgm
0.9
1.0
1.0
0.9
0.8
1.0
0.8
0.9
0.8
0.8
0.6
0.5
0.7
0.7
0.8
0.7
0.6
0.5
0.5
0.7
0.7
Mean
Correction
0.9
0.8
0.7
0.5
0.6
0.5
demonstrate some variation in the initial levels for the different experimental con-
ditions and indicate the possibility of correcting the curves for these initial dif-
ferences.
Values for each subject for each drug at the third, twelfth and twenty-fourth
time periods were used in the correction. The relation of these values to the initial
levels was determined separately for each drug and used to correct the obtained
curves. This was done by computing the regression coefficients of the values at
each of the time periods on the initial levels for each drug condition (5). Table I
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shows the results of these Computations and the correction Values which were
used. The correction for intermediate time periods was based on a linear inter-
polation of the correction values shown in Table 1.
The transformation which has been outlined is analogous to that on which the
statistical analysis of covariation is based. The maj or assumptions are that the
true regression is approximately linear, that the same regression slope approxi-
mately applies to each of the conditions for which a correction is made and that
the obtained values are approximately representative of the true values. The
applicability of the transformation for the correction of the initially obtained
curves is supported by the similarity of the results obtained for each experimental
condition. The importance of the assumptions is minimized by choosing conserva-
tive values for the correction (i.e. values that modify the curves toward, but
which probably fall slightly short of the true curves). Thus, in the event that an
error occurs, it is more likely that the correction is in the right direction, hut
slightly less than would have been made if the true regression values could be
known.
DIscussIoN
Figure 2 shows that the curves for the placebo, 100 and 200 mgm. Frantal and
15 and 30 mgm. Pro-Banthine follow a similar course. At the end of the experi-
ment there tends to be some differentiation between the drugs and placebo. How-
ever the differences between these four drug dosages and the control are not sig-
nificant at the 5 % level of confidence. The differences between drugs and placebo
do occur in the direction which would be anticipated from previous experiments
1w10It2ICI2:jO
FIG. 2. Effect of drugs on GSR level (corrected curves)
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(1, 4) in which atropine, Banthine and Pro-Banthine consistently had a lower
GSR level (increased resistance or decreased sweating) than the control. In the
present study we again see this trend. Furthermore, the 200 mgm. Prantal and 30
mgm. Pro-Banthine dosages seem to produce lower GSR levels than the 100 and
15 mgm. dosages of the corresponding drugs. This suggests that dose-response ef-
fects of varying dosages of anticholinergic drugs can be compared using the
present technic.
Figure 2 shows that both 50 and 100 mgm. of Banthine were followed by pro-
gressively decreasing GSR levels as contrasted with the other drugs and control.
The differences between each dose and the control are statistically significant
beyond the 1 % level of confidence. Also, 100 mgm. Banthine produces a lower
GSR level than 50 mgm. However, both the 50 and 100 mgm. dosages produces
more effect than either dose of Pro-Banthine or Prantal.
CONCLUSIONS
1. The GSR level as described in these experiments can be used to evaluate the
dose-response effects of varying oral dosages of anticholinergic drugs.
2. Orally administered Banthine appears to have a greater effect on the GSR
level than Pro-Banthine or Prantal in the dosages used in the present experi-
ments.
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